Nose-to-Brain Selective Drug Delivery to Glioma via Ferritin-Based Nanovectors Reduces Tumor Growth and Improves Survival Rate

The authors demonstrated that a nanocarrier, named The-0504, could cross the blood-brain barrier and specifically deliver the payload to gliomas that express high amounts of the ferritin/transferrin receptor TfR1 (CD71).